Literature DB >> 26577593

A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants.

Wilfred Ndifon1.   

Abstract

A large number of published studies have shown that adaptive immunity to a particular antigen, including pathogen-derived, can be boosted by another, cross-reacting antigen while inducing suboptimal immunity to the latter. Although this phenomenon, called original antigenic sin (OAS), was first reported approximately 70 years ago (Francis et al. 1947 Am. J. Public Health 37, 1013-1016 (doi:10.2105/AJPH.37.8.1013)), its underlying biological mechanisms are still inadequately understood (Kim et al. Proc. Natl Acad. Sci. USA 109, 13 751-13 756 (doi:10.1073/pnas.0912458109)). Here, focusing on the humoral aspects of adaptive immunity, I propose a simple and testable mechanism: that OAS occurs when T regulatory cells induced by the first antigen decrease the dose of the second antigen that is loaded by dendritic cells and available to activate naive lymphocytes. I use both a parsimonious mathematical model and experimental data to confirm the deductive validity of this proposal. This model also explains the puzzling experimental observation that administering certain dendritic cell-activating adjuvants during antigen exposure alleviates OAS. Specifically, the model predicts that such adjuvants will attenuate T regulatory suppression of naive lymphocyte activation. Together, these results suggest additional strategies for redeeming adaptive immunity from the destructive consequences of antigenic 'sin'.
© 2015 The Author(s).

Keywords:  influenza virus; mathematical modelling; suboptimal immunity; vaccine effectiveness; virus dynamics

Mesh:

Substances:

Year:  2015        PMID: 26577593      PMCID: PMC4685838          DOI: 10.1098/rsif.2015.0627

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  38 in total

1.  Variable efficacy of repeated annual influenza vaccination.

Authors:  D J Smith; S Forrest; D H Ackley; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.

Authors:  A M Thornton; E M Shevach
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

3.  Inducing and expanding regulatory T cell populations by foreign antigen.

Authors:  Karsten Kretschmer; Irina Apostolou; Daniel Hawiger; Khashayarsha Khazaie; Michel C Nussenzweig; Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-10-23       Impact factor: 25.606

Review 4.  The who, how and where of antigen presentation to B cells.

Authors:  Facundo D Batista; Naomi E Harwood
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

5.  Original antigenic sin at the cellular level. I. Antibodies produced by individual cells against cross-reacting haptens.

Authors:  S Deutsch; A E Bussard
Journal:  Eur J Immunol       Date:  1972-08       Impact factor: 5.532

6.  Cutting edge: Heterosubtypic influenza infection antagonizes elicitation of immunological reactivity to hemagglutinin.

Authors:  Jennifer L Nayak; Shabnam Alam; Andrea J Sant
Journal:  J Immunol       Date:  2013-06-21       Impact factor: 5.422

7.  Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells.

Authors:  Aida Ibricevic; Andrew Pekosz; Michael J Walter; Celeste Newby; John T Battaile; Earl G Brown; Michael J Holtzman; Steven L Brody
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

8.  Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.

Authors:  Michael S Turner; Lawrence P Kane; Penelope A Morel
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

9.  Understanding original antigenic sin in influenza with a dynamical system.

Authors:  Keyao Pan
Journal:  PLoS One       Date:  2011-08-29       Impact factor: 3.240

10.  Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus.

Authors:  F M DAVENPORT; A V HENNESSY; T FRANCIS
Journal:  J Exp Med       Date:  1953-12       Impact factor: 14.307

View more
  12 in total

Review 1.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

2.  Comparative Immunogenicity of Enhanced Seasonal Influenza Vaccines in Older Adults: A Systematic Review and Meta-analysis.

Authors:  Tiffany W Y Ng; Benjamin J Cowling; Hui Zhi Gao; Mark G Thompson
Journal:  J Infect Dis       Date:  2019-04-19       Impact factor: 5.226

3.  Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.

Authors:  Danuta M Skowronski; Catharine Chambers; Gaston De Serres; Suzana Sabaiduc; Anne-Luise Winter; James A Dickinson; Jonathan B Gubbay; Kevin Fonseca; Steven J Drews; Hugues Charest; Christine Martineau; Mel Krajden; Martin Petric; Nathalie Bastien; Yan Li; Derek J Smith
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

4.  Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy.

Authors:  Kei Nakashima; Masahiro Aoshima; Satoko Ohfuji; Kanzo Suzuki; Masahiro Katsurada; Naoko Katsurada; Masafumi Misawa; Yoshihito Otsuka; Kyoko Kondo; Yoshio Hirota
Journal:  Hum Vaccin Immunother       Date:  2016-11-07       Impact factor: 3.452

Review 5.  Thyroid Autoantibodies Display both "Original Antigenic Sin" and Epitope Spreading.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Front Immunol       Date:  2017-12-20       Impact factor: 7.561

6.  Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials.

Authors:  Robbert G van der Most; Frédéric Clément; Julie Willekens; Walthère Dewé; Karl Walravens; David W Vaughn; Geert Leroux-Roels
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

Review 7.  Immune History and Influenza Vaccine Effectiveness.

Authors:  Joseph A Lewnard; Sarah Cobey
Journal:  Vaccines (Basel)       Date:  2018-05-21

Review 8.  Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses.

Authors:  Maria Auladell; Xiaoxiao Jia; Luca Hensen; Brendon Chua; Annette Fox; Thi H O Nguyen; Peter C Doherty; Katherine Kedzierska
Journal:  Front Immunol       Date:  2019-07-02       Impact factor: 7.561

9.  An R848-Conjugated Influenza Virus Vaccine Elicits Robust Immunoglobulin G to Hemagglutinin Stem in a Newborn Nonhuman Primate Model.

Authors:  Elene A Clemens; Beth C Holbrook; Masaru Kanekiyo; Jonathan W Yewdell; Barney S Graham; Martha A Alexander-Miller
Journal:  J Infect Dis       Date:  2021-07-15       Impact factor: 5.226

Review 10.  Protective Antibodies Against Influenza Proteins.

Authors:  Herbey O Padilla-Quirarte; Delia V Lopez-Guerrero; Lourdes Gutierrez-Xicotencatl; Fernando Esquivel-Guadarrama
Journal:  Front Immunol       Date:  2019-07-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.